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The role of dynamic contrast-enhanced magnetic
resonance imaging in the diagnosis and
management of patients with vascular
malformations
Michael E. Lidsky, MD,a Charles E. Spritzer, MD,b and Cynthia K. Shortell, MD,a Durham, NC
Objective: Vascular malformations are uncommon but may confer significant morbidity. Limitations in diagnosis and
treatment result from inadequate classification schema and diagnostic algorithms. The crucial distinction is between
high-flow and low-flow lesions because this informs prognosis and treatment. This study assessed the utility of dynamic
contrast-enhanced magnetic resonance imaging (dceMRI) in distinguishing high-flow from low-flow lesions, a technique
that has previously not been widely applied or evaluated in this patient population.
Methods: A prospective database of all patients referred to the multidisciplinary vascular malformation team at our
institution was reviewed from January 2006 to June 2010. dceMRI was obtained on each patient to determine flow
characteristics and lesion extent. Additional studies were used as indicated. Catheter-based arteriography was performed
when high-flow lesions were identified with the intention of intervening or to distinguish between high-flow and
low-flow lesions whenMRI was indeterminate. A triage algorithmwas used to stratify patients and formulate therapeutic
goals. We analyzed the accuracy of dceMRI in identifying high-flow and low-flow lesions.
Results:The study included 122 patients (aged<1 to 70 years) comprising 52males (42.6%) and 70 females (57.4%). Pain
(72 patients; 59%) and swelling (88 patients; 72.1%) were the most common presenting symptoms. All patients
underwent dceMRI. Of these, 68 had confirmatory imaging (n  15) or intervention (n  53). The dceMRI was able to
definitively and correctly distinguish high-flow from low-flow lesions in 57 studies, for an accuracy rate of 83.8%. In the
remaining 11 studies, dceMRI correctly queried flow status but not definitively, and confirmatory angiography was
required.
Conclusions: Using a diagnostic tool designed to identify key clinical characteristics, we were able to successfully
distinguish between high-flow and low-flow vascular malformations using dceMRI alone in 83.8% of patients, minimiz-
ing the need for unnecessary invasive catheter-based procedures. ( J Vasc Surg 2012;56:757-64.)
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mVascular malformations affect only 0.8% to 1% of the
population but are occasionally life-threatening and are
often associated with significant lifelong morbidity.1 In
general, vascular anomalies can be classified as vascular
tumors or vascular malformations. Hemangiomas are the
most common vascular tumor. These are present at birth,
are proliferative lesions, and usually involute spontaneously
during childhood.2 Vascular malformations are also present
at birth and grow at a rate similar to the patient or may not
become clinically evident until later in life. Malformations
have normal endothelial cells and are not proliferative le-
sions; however, they never regress but rather tend to prog-
ress over the patient’s lifetime.2
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an best be accomplished when lesions are classified by their
ascular composition (arterial, venous, lymphatic, or com-
ined) and flow dynamics (high or low flow). The most
ommonly used classification scheme to date was devised in
ome in 1996 by the International Society for the Study of
ascular Anomalies (ISSVA), which delineates vascular tu-
ors from malformations, with an emphasis on vascular
haracteristics.3-6 Prognosis and treatment of vascular mal-
ormations depend primarily on the velocity of flow within
he lesion.7 Low-flow vascular malformations are usually
reated with transcutaneous sclerotherapy or surgical resec-
ion, or both, whereas patients with high-flow lesions usu-
lly require transarterial catheter-based interventions or
urgical resection, or both. Limitations in diagnosis and
reatment of these complex lesions are largely due to inad-
quate classification schema and lack of consistent algo-
ithms for diagnostic evaluation. If the diagnosis of low
ow can be established without the use of catheter-based
rteriography, these patients may be spared the expense,
isk, and inconvenience of a catheter-based study.
In this study, we propose a simplified diagnostic and
reatment algorithm based on vessel and flow characteris-
ics within the lesion that is used for therapeutic decision
aking. We further assess the utility of dynamic contrast-
nhanced magnetic resonance imaging (dceMRI) in distin-
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September 2012758 Lidsky et alguishing between high-flow and low-flow lesions as a
means to optimize treatment and outcome for patients.
This noninvasive diagnostic modality, inadequately de-
scribed in the current body of literature with regard to
vascular malformations, differs from standardMRI in that it
provides images analogous to conventional digital angiog-
raphy. As such, key vascular components are enhanced,
which may provide better definition and more accurate
differentiation between high-flow and low-flow lesions
than conventional MRI.
METHODS
This research was conducted with the approval of the
Institutional Review Board of Duke University Medical
Center, Durham, NC.
Patient selection. Medical records of patients treated
by the multidisciplinary vascular malformation team at
Duke University Medical Center from January 2006 to
June 2010 were retrospectively analyzed. This team con-
sists of vascular surgeons, pediatric surgeons; adult and
pediatric orthopedic surgeons, plastic surgeons, hematolo-
gists, dermatologists, and ophthalmologists; and diagnostic
and interventional radiologists. The teammeets monthly to
review patients.
The database is prospectively maintained and included
122 patients with the diagnosis of vascular malformation at
the time of review. All patients were evaluated by a member
of the vascular malformation team before being presented
at themultidisciplinary conference. The focused data points
in this database were patient demographics, comorbidities,
presenting symptoms, physical examination findings, imag-
ing modalities used, including diagnosis, interventions
used, and outcomes.
Classification of lesions. A diagnostic algorithm was
created and served as a tool to evaluate patients and formu-
late therapeutic goals (Fig 1). In accordance with the
ISSVA classification, this schema differentiates first be-
tween vascular tumors and malformations, both under the
umbrella diagnosis of vascular anomalies.6 Vascular malfor-
Fig 1. This practical scheme to classify vascular anomalies is de-
signed to evaluate patients and formulate diagnostic and therapeu-
tic goals. It focuses on the distinctions that are clinically relevant:
tumors vs malformations and high flow vs low flow. AVM,
Arteriovenous malformation.mations were subdivided further into high-flow and low- vow lesions. Low-flow lesions were separated into venous,
ymphatic, and combined lesions. High-flow lesions in-
lude an arterial component. Patients with vascular tumors
ere excluded from consideration in this study. Patients
ere stratified into their respective lesion group based on
efinitive imaging modalities, in particular dceMRI.
Radiographic workup. A dceMRI was obtained for
very patient deemed a candidate for intervention to deter-
ine flow characteristics and extent of the lesion. Imaging
as principally performed on 1.5T scanners (78.7% on
.5T scanners; 21.3% on 3T scanners; Avanto [Siemens
edical Systems, Malvern, Pa] or Signa hdx [General
lectric Healthcare, Piscataway, NJ]). Multiplanar T1-
eighted spin echo and T2-weighted fast spin echo or fast
hort-tau inversion recovery (STIR) images were initially
btained. Slice thickness, spatial resolution, matrix, and coil
election were dependent on the area to be imaged and the
canner used. A power injectorwas used to administer 5 to 20
L (gadolinium-diethylenetriaminepentaacetate or gadolini-
m-benzyloxypropionictetraacetate) of contrast intrave-
ously. Image acquisition extended from the arterial to the
ate venous phase using time-resolved imaging of contrast
inetics (General Electric), time-resolved echo-shared an-
iographic technique (Siemens), or time-resolved angiog-
aphy with stochastic trajectories (Siemens) dynamic se-
uences.4,8,9 Effective image temporal resolution was 3 to
seconds. Finally, postcontrast T1-weighted spin echo
mages were acquired.
After acquisition, images were reviewed on a Centricity
icture archiving and communication system workstation
General Electric). The dynamic acquisitions produced
ultiple image volume sets, each at a different time point.
ach volume was converted to a maximum-intensity pro-
ection, which was displayed in a fashion such that vessel
nd lesion enhancement were the only structures visual-
zed. The appearance is analogous to a display of a conven-
ional digital angiogram with background subtraction. In-
ividual studies and volume sets were interrogated on a
itrea three-dimensional workstation (Vital Images, Min-
etonka, Minn) as needed. Besides defining the extent of
he abnormality, the interpretations included information
bout the type of vascular malformation as well as the flow
elocity (fast/high or slow/low) within the lesion.
If the dynamic gadolinium-enhanced sequences identi-
ed flow within the lesion at or preceding the visualization
f arterial flow within normal vessels, the lesion was con-
idered to be a high-flow lesion. The presence or absence of
arly venous return from veins draining the lesion or true
mmediate arterial venous shunting (ie, an arterial venous
alformation) through the lesion was commented on. If
he lesion was not apparent on the dynamic gadolinium-
nhanced images until the capillary phase, or more typically
he venous phase, as determined by a comparison with
isualization of normal vessels, the lesion was considered to
e a low-flow abnormality. Prominent venous draining
essels were also commented on.
Additional imaging studies were obtained on an indi-
idual basis when indicated. Specifically, catheter-based
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Volume 56, Number 3 Lidsky et al 759arteriography was performed when high-flow lesions were
identified with the intention of intervening or to distin-
guish between high-flow and low-flow lesions when
dceMRI was indeterminate. Ultrasound (US) imaging and
computed tomography (CT) were also used, although to a
lesser extent, to supplement our understanding of the
lesion (eg, to better evaluate for orbital involvement). We
specifically analyzed the accuracy of dceMRI in identifying
and differentiating high-flow vs low-flow lesions compared
with this study’s gold standards: angiography, CT, US
imaging, or findings during therapeutic procedures. If a
patient had more than one vascular malformation, the
dceMRI protocol did not change; however, multiple acqui-
sitions were required.
Althoughmultiple imaging modalities are available and
provide useful data, dceMRI provides the most critical
information, especially regarding a lesion that will be
treated surgically. The dceMRI not only determines hemo-
dynamic quality but also demonstrates the true extent of
the lesion as well as the soft tissue compartments involved,
all of which become important in planning the surgical
approach. US imaging and other noninvasive studies can
often determine flow quality with less financial expense;
however, the critical lesion anatomy is often not obtained.
RESULTS
During the 54-month review period, 122 patients with
vascular malformations were identified and reviewed at a
monthly multidisciplinary vascular malformation meeting.
Patient demographics included 52 males (42.6%) and 70
females (57.4). Patient ethnicity varied: 71.3% were white,
followed by 13.9% African American and 5.5%Hispanic. At
the time of review, patients were an average age of 26.5
years (range, 1-70 years), with onset of symptoms at age
9.3 years. Patients presented with a variety of symptoms,
including 72 (59%) with pain, 88 (72.1%) with subjective
or physical evidence of swelling, 32 (26.2%) with functional
impairment, and 13 (10.7%) with bleeding. None of the
patients in our series carried a diagnosis of heart failure.
After a complete history and physical examination, each
patient was referred to radiology for dceMRI or other
diagnostic modalities (Fig 2). All 122 patients (100%)
underwent dceMRI. Additional imaging studies performed
selectively included diagnostic catheter-based arteriogra-
phy in 13 (10.7%), US imaging in 17 (13.9%), and CT in
eight (6.6%). The dceMRI was able to definitively charac-
terize the lesion flow in 109 of 122 (89.3%) studies per-
formed. Ninety-three lesions (85.3%) were considered to
be low flow and 16 (14.7%) were considered to be high
flow. The flow characteristics of 13 studies were considered
indeterminate by dceMRI and diagnostic arteriograms
were required. Lesions in five of these 13 studies (38.5%)
were high-flow and eight (61.5%) were low-flow abnormal-
ities. The location of dceMRI indeterminate lesions in-
cluded one visceral lesion (7.7%), four head/neck lesions
(30.8%), four upper extremity lesions (30.8%), and four
lower extremity lesions (30.8%). wCombining the dceMRI and angiography interpreta-
ions when the dceMRI study was indeterminate resulted in
1 lesions (17.2%) being diagnosed as high-flow vascular
alformations, with 101 (82.8%) being low-flow malfor-
ations. The relative proportion of high-flow to low-flow
esions is consistent with previous studies identifying nearly
ll lesions to be low flow.10-12
In 68 cases, dceMRI diagnoses were validated by sec-
ndary imaging modalities (15 lesions) or more commonly
t the time of intervention (53 lesions), serving as the gold
tandard for comparison, which is the basis of further
iscussion and conclusions. Of these 68 lesions, 14 (20.6%)
ere proven to be high flow and 54 (79.4%) low flow.
In 46 of these 68 cases (67.6%), dceMRI definitively
iagnosed low-flow lesions. Flow characteristics were vali-
ated as correct in each instance at the time of percutaneous
ntervention in 42 lesions or withUS imaging in two lesions
nd with CT in two lesions (Table). Another eight cases
ere considered likely to be low-flow lesions at the time of
ceMRI interpretation, but there was insufficient confi-
ence or confounding issues that precluded a definitive
iagnosis and as such were considered indeterminate.
hese eight cases necessitated catheter-based arteriograms,
hich confirmed the suspicion of low-flow physiology
ithin all eight. Percutaneous interventions for the 54
ceMRI-diagnosed low-flow lesions, including those that
equired a secondary diagnostic modality, used US or flu-
roscopic guidance, at which time none of these lesions was
ound to have a high-flow component.
The lack of communication with the arterial system was
etermined in several ways. In lesions treated with US or
uoroscopic guidance, the absence of pulsatile back bleed-
ng at the time of access ruled out a high-flow component.
n addition, lesions were successfully treated without com-
lications of arterial sclerosant injection.
The dceMRI study correctly and definitively diagnosed
1 of 14 high-flow lesions (78.6%) in these 68 cases. These
ig 2. A variety of diagnostic studies were used, including dy-
amic contrast-enhanced magnetic resonance imaging (dceMRI)
n 122 patients (100%), ultrasound (US) imaging in 17 (13.9%),
atheter-based arteriography in 13 (10.7%), and computed tomog-
aphy (CT) in eight (6.6%).ere typically followed with catheter-based arteriograms to
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September 2012760 Lidsky et alconfirm the diagnosis and for intervention, as indicated.
Although suggestive of high-flow lesions in the remaining
three cases, confidence in the dceMRI findings was insuffi-
cient for a definitive diagnosis and diagnostic arteriography
was requested. The final diagnosis was correct in each of
these three presumed high-flow lesions. Further, 100% of
the 14 presumed high-flow lesions did have high-flow
physiology at the time of intervention.
When considering the 68 lesions with objective proof
of hemodynamic physiology, dceMRI correctly and defin-
itively diagnosed lesion flow in 57. Although none of the
dceMRI indeterminate interpretations was actually incor-
rect, if we consider them all incorrect for statistical pur-
poses, dceMRI was able to definitively distinguish slow-
flow from fast-flow lesions with an overall accuracy rate of
83.8%. Again, making the worst-case assumption that all
indeterminate interpretations were incorrect, the sensitivity
and specificity of dceMRI for diagnosing high-flow lesions
in these 68 cases was 78.6% and 85.2%, respectively. The
positive predictive value was 57.9% and the negative pre-
dictive value was 93.9% for high-flow lesions diagnosed by
dceMRI. Using the same assumptions, dceMRI was 85.2%
sensitive and 78.6% specific for diagnosing low-flow le-
sions, with a positive predictive value and negative predic-
tive value of 93.9% and 57.9%, respectively.
Of the seven high-flow lesions in which no intervention
was implemented, two patients (28.6%) are currently con-
sidering therapy, two (28.6%) were advised against inter-
vention because their lesions were relatively asymptomatic,
one patient’s (14.3%) socioeconomic status prohibited an
intervention, and one patient (14.3%) was lost to follow-
Table. Objective evidence of dynamic contrast-enhanced m
Confirming modality
dceMRI det
High flow
Ultrasound 0
Computed tomography 0
Angiography 0
Intervention/surgery 11
Total 11
dceMRI accuracy (all lesions) 83.8%
Lesions Sensitivity
High-flow, % 78.6
Low-flow, % 85.2
Statistic
dceMRI HFVM No. –HFVM
Determinate True positive 11 False positive
Indeterminate False negative 3 True negative
HFVM, High-flow vascular malformation; LFVM, Low-flow vascular malfo
aTo assess proof of flow quality determined by dceMRI, 68 dceMRI-diagn
Accuracy, sensitivity, specificity, PPV, and NPV of dceMRI are indicated. Cup. The remaining patient (14.3%) patient died of a sus- pected pulmonary embolus after a diagnostic arteriogram
o further evaluate the flow characteristics within a high-
ow femoral malformation. This patient, whose high-flow
esion was an isolated finding, had no history of deep
enous thrombosis and the results of a hypercoagulable
orkup were within normal limits.
ISCUSSION
Vascular anomalies can be of the tumor or malforma-
ion type.13 The most common type of vascular tumor is a
emangioma,which presents at birth orwithin the first several
eeks of life, may range from mild to life-threatening in
ature, depending on its location, and is typically small and
nvolves the skin. They grow rapidly over the course of the first
everal years and then universally involute spontaneously dur-
ng childhood.14,15 The management of such lesions may
nclude observation alone, medical therapy with steroids or
ropranolol, or even surgical resection, depending on the
everity of the lesion, the area involved, and the extent of
he residual irregularity during or after the involution
tage.14,15 Vascular malformations, by contrast, are present
t birth but may not be clinically evident immediately and
ever undergo spontaneous regression.16
Unfortunately, lack of awareness of these distinctions
nd persistence of an archaic, eponymous naming system
as interfered with appropriate and timely recognition of
he nature of these lesions and therefore referral to a
pecialist. In fact, Konez et al17 reported nearly half of the
atients referred to a vascular malformation specialist by
roviders relatively unfamiliar with the disease had been
etic resonance imaging (dceMRI) accuracya
ant dceMRI indeterminate
Low flow High flow Low flow
2 0 0
2 0 0
0 3 8
42 0 0
46 3 8
dceMRI
pecificity PPV NPV
85.2 57.9 93.9
78.6 93.9 57.9
nitions
No. LFVM No. –LFVM No.
8 True positive 46 False positive 3
46 False negative 8 True negative 11
n; NPV, negative predictive value; PPV, positive predictive value.
lesions underwent secondary imaging modalities or intervention/surgery.
for each statistical calculation are also included.agn
ermin
S
al defi
rmatioreviously diagnosed inaccurately.
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Volume 56, Number 3 Lidsky et al 761Almost 30 years ago, Mulliken and Glowacki13 classi-
fied vascular lesions based on endothelial characteristics.
This classification was updated in 1996 by Mulliken and
Young,18 which includes specific diagnoses. To date, there
have been a number of other modifications and up-
dates.19-22 These classification systems continue to evoke
confusion in arriving at a proper diagnosis.23
Contemporary studies have successfully proposed clas-
sification schemes that assist in confirming a named diag-
nosis.24 To date, the most commonly used classification
scheme, which was devised in Rome in 1996 by the ISSVA,
delineates vascular tumors from malformations, with an
emphasis on vascular characteristics.3-6 However, deriving
a treatment plan from even this criteria remains challeng-
ing.25
Although the ISVVA classification scheme has been
validated and is clinically applicable, our intention was to
streamline this widely used classification scheme to create a
therapy-directed treatment algorithm based on flow char-
acteristics and hemodynamic physiology.26 Here, we dem-
Fig 3. A low-flow vascular malformation is seen in conv
imaging. A, A short-tau inversion recovery (STIR) im
vascular malformation is seen in early arterial throug
resonance imaging.onstrate the utility of this application of the prior ISSVA blassification scheme. The simple and practical diagnostic
chema proposed and used in this study focuses on arriving
t diagnoses stratified by basic lesion characteristics and
ow qualities, which is the foundation for which prognosis
nd treatment can be formulated. The classification algo-
ithm presented in this study was not compared with his-
oric classification systems, including the ISSVA schema,
ith regard to patient outcomes; however, the current
chema is built on and simplified from the ISSVA system,
nd we suspect they have similar utility.
The ability to distinguish between high-flow and low-
ow lesions when using noninvasive imaging modalities is
ssential when the goal is to avoid unnecessary invasive
atheter-based procedures. In fact, distinguishing a high-
ow lesion from a low-flow lesion is more important for
rognostic and therapeutic purposes than determining the
articular makeup of the lesion (arterial vs venous vs lym-
hatic).10,12,27-29 Multiple diagnostic modalities can be
sed to evaluate vascular malformations and confirm the
nitial clinical diagnosis. US imaging, CT scans, catheter-
nal and dynamic contrast-enhanced magnetic resonance
f a low-flow vascular malformation. B-D, A low-flow
venous phase dynamic contrast-enhanced magneticentio
age o
h lateased angiography, and MRI are often used, alone or
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September 2012762 Lidsky et alcombined, to identify the lesion and its vascular character-
istics.14 US imaging is an inexpensive and readily available
tool to investigate vascular malformations but is often
unable to demonstrate the true extent of the lesion.30
dceMRI yields more information, including flow character-
istics, soft tissue involvement, and the relationship to nor-
mal anatomy.31 Although not the scope of this study, a
number of studies have summarized the findings for each
modality.14,31-33
Specific to MRI, the parenchymal portions of vascular
lesions are quite bright on T2-weighted images, and the
extent of tissue involvement is readily depicted when T1
and T2 (or STIR) images are acquired.14 Low-flowmalfor-
mations characteristically have increased intraluminal signal
on T2-weighted images (Fig 3). There is likely an intralu-
minal signal on the T1-weighted images as well. These
lesions enhance with contrast and typically do not contain
flow voids. A low signal in such malformations is concern-
ing for thrombosis. A very focal area of signal abnormality
may also represent a phlebolith.31 High-flow arteriovenous
Fig 4. A high-flow vascular malformation is seen in conv
imaging. A, A short-tau inversion recovery (STIR) ima
vascular malformation is seen in early arterial throug
resonance imaging.malformations typically do contain flow voids that can be fbserved on T1- and T2-weighted images, distinguishing
hem from low-flow lesions.10,14,28,31,34 Dilated feeding
rteries and draining veins with a paucity of venous lakes are
lso indicative of high-flow lesions (Fig 4).31
However, distinguishing between low- and high-flow
esions is often unclear using the simple imaging techniques
nd rules described above. Many particulars can mitigate
hese observations; for example, a vessel that courses within
n imaging plane may produce an intraluminal signal de-
pite fairly rapid flow, falsely suggesting a low-flow lesion.
s such, dceMRI using techniques, such as TRICKS (time-
esolved imaging of contrast kinetics) and TREAT (time-
esolved echo-shared angiographic technique), are re-
uired to accurately assess flow within the lesion.4,5 These
echniques have the added advantage of being able to
elineate dominant or multiple feeding vessels in these
esions, potentially facilitating intervention.
In 2002, Rijswijk et al35 published prospective data
hat resulted from blinding two independent observers as
hey reviewed conventional MRI and dceMRI studies per-
nal and dynamic contrast-enhanced magnetic resonance
a high-flow vascular malformation. B-D, A high-flow
venous phase dynamic contrast-enhanced magneticentio
ge of
h lateormed on patients with clinically suspected high-flow vas-
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Volume 56, Number 3 Lidsky et al 763cular malformations. All patients underwent dceMRI as
well as diagnostic angiography. This group observed an
increase in the specificity of MRI from 24% to 33% to 95%
with the addition of dynamic contrast-enhanced sequences.
Although the Rijswijk study included only 27 patients, our
study of 122 patients, 68 with objective confirmation,
confirms with overwhelming evidence that dceMRI is the
diagnostic study of choice. In our study group, clinically
relevant high-flow lesions were never missed on dceMRI:
none of the dceMRI-diagnosed low-flow vascular malfor-
mations treated invasively had a high-flow component, and
flow quality of indeterminately diagnosed low-flow vascular
malformations was confirmed with secondary studies.
dceMRI alone proved sufficient to diagnose flow character-
istics in at least 83.8% of patients. The location of the lesion
does not appear to correlate with a resulting indeterminate
dceMRI, and there were no obvious patient-specific or
lesion-specific characteristics that predicted indeterminate
imaging studies.
The dceMRI data were used to determine and imple-
ment appropriate lesion management, as described in the
Appendix (online only).36 The hemodynamic and ana-
tomic characteristics determined by dceMRI allowed for
implementation of catheter-based embolization for high-
flow lesions, or transcutaneous sclerotherapy for low-flow
lesions, with or without surgical resection, depending on
the extent of the lesion, cystic quality, and involvement of
vital structures. In the setting of determinate studies,
dceMRI diagnoses provided sufficient evidence to inter-
vene without further investigation. However, indetermi-
nate dceMRI results were always followed with secondary
imaging (ie, diagnostic angiography) in patients requiring
invasive treatment. Because this was not the focus of this
study, a separate publication will include a comprehensive
review of management strategies with respect to patient
outcomes and response to treatment.
Catheter-based procedures have traditionally been the
standard of reference for assessing vascular malformations;
however, such procedures are not entirely benign and entail
some risk to the patient. Complications observed with
endovascular procedures occur in 1.5% to 9% of patients
and include groin hematoma, pseudoaneurysm, arterio-
venous fistula, acute arterial occlusion or thrombosis, em-
bolic events, and infection.37,38 Although some of these
complications can be managed conservatively, 11% of
groin hematomas and 61% of pseudoaneurysms will neces-
sitate another procedure or perhaps an operation.38 Sub-
jecting patients to these risks, albeit small, adds to the
morbidity of the vascular lesion fromwhich they are already
suffering. In this study, dceMRI was able to obviate more
invasive diagnostic imaging in 83.8% of the cases. When
dceMRI is not definitive in assessing flow status, arteriog-
raphy can then be performed not only to confirm the
diagnosis but also to provide an opportunity to intervene in
the case of high-low abnormalities. Such an approach
avoids unnecessary diagnostic arteriograms in most pa-
tients. AThis study has several limitations. First, because Duke
niversity Medical Center is a referral center, many of the
atients discussed at our monthly multidisciplinary confer-
nce already carry a diagnosis and are in need of treatment
r have already undergone multiple and often excessive or
nnecessary imaging studies that may or may not have led
o an accurate diagnosis. Imaging studies from other facil-
ties were reviewed by the team radiologist and were avail-
ble when dceMRI studies were protocoled and inter-
reted.
Further, only symptomatic patients underwent inter-
entions; therefore, the conclusions drawn by the imaging
tudies regarding a particular lesion were not always con-
rmed because treatment was not always performed. In
act, to definitively confirm the diagnosis arrived at by
ceMRI, each patient should have undergone catheter-
ased angiography. However, this was not feasible due to
he retrospective nature of this study and may not be
cceptable in future studies because of the added risk
ntrinsic with the procedure.
The most obvious shortcoming of this study is that
atients were retrospectively analyzed. A prospective study
hat obtains conventional and dceMRI sequences, and
erhaps conventional angiograms, on every patient to be
eviewed blindly by expert radiologists in this field may
ore definitively assess the utility of dceMRI to accurately
istinguish high-flow from low-flow vascular malforma-
ions.
ONCLUSIONS
Management of vascular malformations requires an
ccurate diagnosis before intervening. The correction of
emodynamic abnormalities, particularly in high-flow le-
ions, must occur before functional or cosmetic procedures
an take place.39 Based on the results of this study, we
ropose dceMRI as the mainstay of diagnostic evaluation
or patients with suspected vascular malformations. Infor-
ation obtained from such imaging allows the patient to be
tratified into a high-flow or low-flow vascular malforma-
ion group based on a simplified diagnostic stratification
cheme, such that an appropriate therapeutic plan can be
ormulated and unnecessary invasive testing can be avoided
n most patients. Although the primary focus of this study
as on the utility of dceMRI to differentiate between
igh-flow and low-flow vascular malformations, future di-
ections will include a comprehensive institutional review of
anagement strategies with respect to patient outcomes
nd response to treatment.
This study would not have been possible without the
are and commitment of Carol Fisher, who serves as the
ultidisciplinary Vascular Malformation Team Coordina-
or, as well as JovanMarkovic, MD, for his contributions to
he vascular malformation database.
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Brief description of treatment algorithm. Once a
patient is diagnosed with a vascular malformation and
further stratified as having a high-flow or low-flow lesion, a
discussion is held with the patient regarding prognosis and
treatment options. Similar to the absolute and relative
indications for treatment outlined by Lee et al,36 only
patients who are symptomatic are considered candidates for
invasive therapy given the potential for additional morbid-
ity related to any intervention.
In our practice, symptomatic low-flow lesions (venous,
lymphatic, or combined) are treated with ultrasound or
fluoroscopic-guided percutaneous foam or liquid sclero-
therapy (sodium tetradecyl sulfate, polidocanol, or ethanol,
or a combination) or surgical resection, or both. Low-flow
lesions that are superficial, localized, microcystic or sep- cated, and encapsulated are typically excised, primarily be-
ause the sclerosant does not distribute homogenously
hroughout the lesion, whereas diffuse, extensive, macro-
ystic lesions involving multiple tissue planes or vital struc-
ures (ie, nerves) are treated with sclerotherapy because
xcision is often unfeasible. The sclerosant of choice is
ypically physician-dependent, but most lesions are treated
ith sodium tetradecyl sulfate or polidocanol (81.6% foam
s 18.4% ethanol). It is not uncommon for patients to
equire multiple sclerotherapy sessions until satisfactory
mprovement or resolution of symptoms is attained.
High-flow lesions, however, are typically treated with
ransarterial catheter-based techniques (also often requiring
ultiple sessions) that result in significant obliteration of the
esion’s central component without compromising inflow ac-
ess, with or without subsequent surgical resection.
